{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:17:51Z","timestamp":1790687871968,"version":"4.1.0"},"reference-count":18,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T00:00:00Z","timestamp":1644451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000038","name":"United States Food and Drug Administration","doi-asserted-by":"publisher","award":["Perinatal Health Center of Excellence (PHCE) project grant #GCBER005"],"award-info":[{"award-number":["Perinatal Health Center of Excellence (PHCE) project grant #GCBER005"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["75D30120C07725"],"award-info":[{"award-number":["75D30120C07725"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Mucosal immunity plays an important role in the control of viral respiratory infections like SARS-CoV-2. While systemic immune responses against the SARS-2-CoV-2 have been studied in children, there is no information on mucosal antibody response, especially in the lower respiratory tract of children coronavirus disease 2019 (COVID-19) and post-infectious multisystem inflammatory syndrome in children (MIS-C) against emerging SARS-CoV-2 variants. Therefore, we evaluated neutralizing antibody responses in paired plasma and endotracheal aspirates of pediatric severe, acute COVID-19 or MIS-C patients against SARS-CoV-2 WA1\/2020, as well as against variants of concern (VOCs). Neutralizing antibody responses against the SARS-CoV-2 WA1\/2020 strain in pediatric plasma were 2-fold or 35-fold higher compared with the matched endotracheal aspirate in COVID-19 or MIS-C patients, respectively. In contrast to plasma, neutralizing antibody responses against the VOCs and variants of interest (VOIs) in endotracheal aspirates were lower, with only one endotracheal aspirate demonstrating neutralizing titers against the Iota, Kappa, Beta, Gamma, and Omicron variants. In conclusion, our findings suggest that children and adolescents with severe COVID-19 or MIS-C have weak mucosal neutralizing antibodies in the trachea against circulating SARS-CoV-2 Omicron and other VOCs, which may have implications for recovery and for re-infection with emerging SARS-CoV-2 variants.<\/jats:p>","DOI":"10.3390\/vaccines10020270","type":"journal-article","created":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T02:40:17Z","timestamp":1644547217000},"page":"270","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Systemic and Lower Respiratory Tract Immunity to SARS-CoV-2 Omicron and Variants in Pediatric Severe COVID-19 and Mis-C"],"prefix":"10.3390","volume":"10","author":[{"given":"Juanjie","family":"Tang","sequence":"first","affiliation":[{"name":"Center for Biologics Evaluation and Research (CBER), Division of Viral Products, Food and Drug Administration (FDA), Silver Spring, MD 20993, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3084-3071","authenticated-orcid":false,"given":"Adrienne G.","family":"Randolph","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Critical Care and Pain Medicine, Department of Anesthesia, Harvard Medical School, Boston Children\u2019s Hospital, Boston, MA 02115, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Novak","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Critical Care and Pain Medicine, Department of Anesthesia, Harvard Medical School, Boston Children\u2019s Hospital, Boston, MA 02115, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracie C.","family":"Walker","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of North Carolina at Chapel Hill Children\u2019s Hospital, Chapel Hill, NC 27514, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura L.","family":"Loftis","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Critical Care Medicine, Baylor College of Medicine, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt S.","family":"Zinter","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Divisions of Critical Care and Bone Marrow Transplantation, University of California, San Francisco, CA 94158, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Irby","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Critical Care Medicine, Arkansas Children\u2019s Hospital, Little Rock, AR 72202, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surender","family":"Khurana","sequence":"additional","affiliation":[{"name":"Center for Biologics Evaluation and Research (CBER), Division of Viral Products, Food and Drug Administration (FDA), Silver Spring, MD 20993, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,2,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1056\/NEJMoa2021680","article-title":"Multisystem Inflammatory Syndrome in U.S. Children and Adolescents","volume":"4","author":"Feldstein","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41591-021-01263-3","article-title":"Humoral signatures of protective and pathological SARS-CoV-2 infection in children","volume":"3","author":"Bartsch","year":"2021","journal-title":"Nat. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/s41590-021-01051-8","article-title":"SARS-CoV-2 immune repertoire in MIS-C and pediatric COVID-19","volume":"22","author":"Ravichandran","year":"2021","journal-title":"Nat. Immunol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/d41586-022-00215-2","article-title":"Where did Omicron come from? Three key theories","volume":"7895","author":"Mallapaty","year":"2022","journal-title":"Nature"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41577-022-00678-4","article-title":"Milder disease with Omicron: Is it the virus or the pre-existing immunity?","volume":"22","author":"Sigal","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Planas, D., Saunders, N., Maes, P., Guivel-Benhassine, F., Planchais, C., Buchrieser, J., Bolland, W.H., Porrot, F., Staropoli, I., and Lemoine, F. (2021). Considerable escape of SARS-CoV-2 Omicron to antibody neutralization. Nature, 1\u20137.","DOI":"10.1038\/d41586-021-03827-2"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Liu, L., Iketani, S., Guo, Y., Chan, J.F., Wang, M., Liu, L., Luo, Y., Chu, H., Huang, Y., and Nair, M.S. (2021). Striking Antibody Evasion Manifested by the Omicron Variant of SARS-CoV-2. Nature.","DOI":"10.1038\/d41586-021-03826-3"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Cele, S., Jackson, L., Khoury, D.S., Khan, K., Moyo-Gwete, T., Tegally, H., San, J.E., Cromer, D., Scheepers, C., and Amoako, D.G. (2021). Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization. Nature.","DOI":"10.1038\/d41586-021-03824-5"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"103006","DOI":"10.1016\/j.isci.2021.103006","article-title":"Epitope diversity of SARS-CoV-2 hyperimmune intravenous human immunoglobulins and neutralization of variants of concern","volume":"24","author":"Tang","year":"2021","journal-title":"IScience"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"eabc3539","DOI":"10.1126\/scitranslmed.abc3539","article-title":"Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits","volume":"12","author":"Ravichandran","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Neerukonda, S.N., Vassell, R., Herrup, R., Liu, S., Wang, T., Takeda, K., Yang, Y., Lin, T.L., Wang, W., and Weiss, C.D. (2021). Establishment of a well-characterized SARS-CoV-2 lentiviral pseudovirus neutralization assay using 293T cells with stable expression of ACE2 and TMPRSS2. PLoS ONE, 3.","DOI":"10.1101\/2020.12.26.424442"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"eabi6533","DOI":"10.1126\/sciadv.abi6533","article-title":"Systemic and mucosal immune profiling in asymptomatic and symptomatic SARS-CoV-2-infected individuals reveal unlinked immune signatures","volume":"7","author":"Ravichandran","year":"2021","journal-title":"Sci. Adv."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Jamison, D.T., Breman, J.G., Measham, A.R., Alleyne, G., Claeson, M., Evans, D.B., Jha, P., Mills, A., and Musgrove, P. (2006). Acute Respiratory Infections in Children. Disease Control Priorities in Developing Countries, World Bank. [2nd ed.].","DOI":"10.1596\/978-0-8213-6179-5"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12519-021-00511-3","article-title":"Role of Omicron variant of SARS-CoV-2 in children in Germany","volume":"18","author":"Bittmann","year":"2022","journal-title":"World J. Pediatr."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Pawlowski, P. (2021). SARS-CoV-2 variant Omicron (B.1.1.529) is in a rising trend of mutations increasing the positive electric charge in crucial regions of the spike protein S. Acta Biochim. Pol., 68.","DOI":"10.18388\/abp.2020_6072"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1016\/S0140-6736(21)02758-6","article-title":"Omicron SARS-CoV-2 variant: A new chapter in the COVID-19 pandemic","volume":"398","author":"Karim","year":"2021","journal-title":"Lancet"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"eabd2223","DOI":"10.1126\/scitranslmed.abd2223","article-title":"IgA dominates the early neutralizing antibody response to SARS-CoV-2","volume":"13","author":"Sterlin","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S2352-4642(21)00196-6","article-title":"Evidence of lung perfusion defects and ongoing inflammation in an adolescent with post-acute sequelae of SARS-CoV-2 infection","volume":"5","author":"Buonsenso","year":"2021","journal-title":"Lancet Child Adolesc. Health"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/10\/2\/270\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:17:35Z","timestamp":1760134655000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/10\/2\/270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,10]]},"references-count":18,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["vaccines10020270"],"URL":"https:\/\/doi.org\/10.3390\/vaccines10020270","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,10]]}}}